March 6, 2025 - 18:38
Solidion has successfully obtained an extension until May 30, 2025, to comply with NASDAQ's minimum bid requirement of $1 per share. This extension is crucial for the company as it navigates the challenges of maintaining its listing on the stock exchange.
The company is exploring various strategies to enhance its stock price, including the possibility of a reverse stock split. A reverse split could potentially consolidate shares, thereby increasing the per-share price, which may help Solidion meet NASDAQ's listing standards.
This extension provides Solidion with additional time to implement measures aimed at improving its market performance and investor confidence. The management team is optimistic about the company's future and is committed to executing a plan that will not only satisfy NASDAQ's requirements but also foster long-term growth.
As Solidion works to stabilize its stock price, stakeholders will be closely monitoring the company's progress and strategic decisions in the coming months.
June 7, 2025 - 20:23
Yageo Corp. to Retain Shibaura's AI Technology in Japan Following AcquisitionTaiwan`s Yageo Corp. has announced its intention to maintain the advanced artificial intelligence technology of Shibaura Electronics Co. in Japan, contingent upon a successful acquisition of the...
June 7, 2025 - 00:28
Pankaj K. Jha Awarded NSF Grant for Quantum Technology ResearchPankaj K. Jha, a prominent professor in the field of quantum technology, has recently been awarded a significant grant from the National Science Foundation (NSF) to further his research on...
June 6, 2025 - 01:39
Utilizing Smart Manufacturing Technology for the Next Generation of CNC MachinistsIn an era marked by rapid technological advancements, the manufacturing industry faces a pressing challenge: bridging the skills gap in the workforce. As smart manufacturing technologies continue...
June 5, 2025 - 09:18
FDA Greenlights Innovative AI Tool for Enhanced Breast Cancer DetectionA groundbreaking development in breast cancer detection has received approval from the FDA. This new AI technology, created by a pioneering tech company, marks the first instance of an FDA-approved...